CLDX Research and Charts

CLDX - Celldex Therapeutics Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-05 (Delayed quote data 2025-07-11)

Last 22.91	Change ⇑ +0.23 (+1.01%)	Volume 803,217
	Open 22.64	High 23.48	Low 22.50

8EMA (Daily) 22.03	40EMA (Daily) 20.85	50EMA (Daily) 20.74	STO (Daily) 76.991	MACD Hist (Daily) 0.340
8EMA (Weekly) 21.242	40EMA (Weekly) 23.67	50EMA (Weekly) 24.82	STO (Weekly) 73.271	MACD Hist (Weekly) 1.396


Company Profile
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.